Delivery Order SPE2DB22D3401-SPE2DB25FT3HJ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Tenivac syringes (0.5mL) with a ceiling value of $1,571.09. This competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be fulfilled from the company's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Tenivac syringes (0.5ml) under a firm fixed-price contract valued at $1,816.08. The order represents a non-set-aside competitive award with an ultimate completion date of August 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Tenivac syringes (0.5mL) with a ceiling value of $1,135.05. This is a firm fixed-price contract with an ultimate completion date of August 27, 2025, and represents a non-competitive set-aside order. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. This delivery order is a child contract...
- This delivery order, issued on June 12, 2025, represents a $1,066.80 firm fixed-price award to AmerisourceBergen Drug Corp for the supply of Tenivac syringes (0.5ML) under a competitive procurement with no set-aside designation. The Defense Logistics Agency, which funds this award, will receive delivery by June 13, 2025, with performance executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract executed against...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Tenivac syringes (0.5ML) under a firm fixed-price contract valued at $1,231.56. This non-competitive, non-set-aside delivery order is scheduled for completion by December 18, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine procurement action for medical supplies supporting...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,362.06 by the Defense Logistics Agency on August 12, 2025, for the supply of Tenivac syringes in 0.5 mL quantities. The contract is a firm fixed price delivery order with an ultimate completion date of August 13, 2025, and represents a non-competitive set-aside award. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- This delivery order, valued at $1,135.05, awards AmerisourceBergen Drug Corp the supply of Tenivac syringes (0.5mL) under a firm fixed price arrangement. The contract was competitively awarded without set-aside restrictions and is scheduled for completion by September 4, 2025. AmerisourceBergen will perform delivery from its corporate office location in Conshohocken, Pennsylvania. This award is funded by the Defense Logistics Agency (DLA), a component of the Department of Defense, which procures...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Tenivac syringes (0.5 mL) with a ceiling value of $1,203.82. This is a firm fixed-price delivery order with an ultimate completion date of June 2, 2025, and represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor serving military and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,833.07 to AmerisourceBergen Drug Corp for Tenivac syringes (0.5mL) on December 3, 2025, with a completion date of December 4, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract was awarded competitively with no set-aside...
- The Defense Logistics Agency awarded a $3,078.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 0.5mL Tenivac syringes, with an ultimate completion date of December 12, 2025. This non-set-aside competitive award represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The syringes will be delivered to the contractor's corporate office location in...
- SPE2DB22D3401Indefinite Delivery Contract
- SPE2DB22D3401-SPE2DB25FT3HJDelivery Order
This delivery order, awarded on April 23, 2025, represents a $1,048.43 firm fixed-price purchase of Tenivac syringes (0.5mL) from AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The Defense Logistics Agency (DLA), under the Department of Defense, funded this non-competitive delivery order, with performance to be completed by April 24, 2025. This contract is a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026, which serves as the company's comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp's prime IDV with DLA enables the company to supply an extensive range of pharmaceutical products and medical supplies—including specialty medications, vaccines, syringes, and test kits across multiple therapeutic domains—to support Defense Health Agency operations and other government healthcare systems. The firm fixed-price delivery order structure and non-set-aside designation reflect the company's established capability to meet federal medical procurement requirements. This syringe delivery represents routine medical supply fulfillment under the broader strategic pharmaceutical prime vendor framework, supporting ongoing military healthcare logistics operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 4/23/25 |